Opthea Ltd has released a press release.
Opthea EURetina Symposium 2024
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Opthea
- Opthea Joins the S&P/ASX 300 Index
- Opthea Announces Completion of Drug Substance Campaign
- Opthea Corporate Presentation - September 2024
- S&P DJI Announces September 2024 Quarterly Rebalance
- Opthea Reports Full-Year Results
Later from Opthea
- Opthea Corporate Presentation - Oct 2024
- Chair's Address to Shareholders
- Opthea Received A$15.9 Million R&D Tax Incentive
- Opthea's Wet AMD Program to be Featured at FLORetina 2024
- Opthea Announces Publication in Diabetic Macular Edema
Follow Opthea into a list and get an email when it puts out news.
Follow Opthea